Case Study: Digital Biomarkers in Oncology Trials
Case Study: Digital Biomarkers in Oncology Trials Real-World Implementation of Digital Biomarkers in Oncology Trials Introduction: The Shift Toward Remote Oncology Monitoring Oncology trials have traditionally relied on clinic-based assessments and invasive tests to monitor disease progression and treatment toxicity. However, the burden on patients—many of whom are frail or immunocompromised—can be immense. Digital biomarkers…
Read More “Case Study: Digital Biomarkers in Oncology Trials” »